Karriereverlauf von Phillips N. Dee
Ehemalige bekannte Positionen von Phillips N. Dee
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
RegenoCELL Therapeutics, Inc.
 RegenoCELL Therapeutics, Inc. BiotechnologyHealth Technology RegenoCELL Therapeutics, Inc. develops a stem-cell therapy business for the treatment of congestive heart failure and peripheral artery disease. It utilizes adult stem cells, derived from the patient's own blood, which eliminates the ethical and safety concerns associated with embryonic and umbilical cord blood stem cells. The stem cell therapy is either delivered through a catheter or injected directly into the myocardium. The company was founded by Scott Massey on February 1, 2002 and is headquartered in Natick, MA. | Direktor/Vorstandsmitglied | 01.02.2002 | 16.07.2008 |
Ausbildung von Phillips N. Dee
| The University of North Carolina at Charlotte | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Director/Board Member | 1 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
RegenoCELL Therapeutics, Inc.
RegenoCELL Therapeutics, Inc. BiotechnologyHealth Technology RegenoCELL Therapeutics, Inc. develops a stem-cell therapy business for the treatment of congestive heart failure and peripheral artery disease. It utilizes adult stem cells, derived from the patient's own blood, which eliminates the ethical and safety concerns associated with embryonic and umbilical cord blood stem cells. The stem cell therapy is either delivered through a catheter or injected directly into the myocardium. The company was founded by Scott Massey on February 1, 2002 and is headquartered in Natick, MA. | Health Technology |
- Börse
- Insiders
- Phillips N. Dee
- Erfahrung
